[The polypill: optimal strategy for reduction of cardiovascular disease]
- PMID: 16114290
[The polypill: optimal strategy for reduction of cardiovascular disease]
Abstract
Treating all persons above 55 years of age with a polypill for primary and secondary cardiovascular-disease prevention may reduce cardiovascular events by more than 80%. This strategy is expected to be cost-effective and the associated risk of side effects is estimated to be low.
Comment in
-
[The polypill: not an effective strategy for reduction of cardiovascular disease].Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1741. Ned Tijdschr Geneeskd. 2005. PMID: 16114291 Dutch.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical